BIOMAT Database Logo BIOMAT Database Logo

Efficacy of oral poliovaccine in infancy. 1977

N S Pangi, and J M Master, and K H Dave

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D004770 Enterovirus A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus". Coxsackie Viruses,Coxsackieviruses
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

N S Pangi, and J M Master, and K H Dave
ORAL POLIOVACCINE.
November 1963, JAMA,
N S Pangi, and J M Master, and K H Dave
Oral poliovaccine and paralysis.
October 1968, Indian pediatrics,
N S Pangi, and J M Master, and K H Dave
Problems with oral poliovaccine in India.
May 1972, Indian pediatrics,
N S Pangi, and J M Master, and K H Dave
Intratypic serodifferentiation of oral poliovaccine progeny.
June 1965, Acta Scholae Medicinalis Universitatis in Kioto,
N S Pangi, and J M Master, and K H Dave
A critical look at oral poliovaccine.
February 1963, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
N S Pangi, and J M Master, and K H Dave
Stabilising oral poliovaccine at high ambient temperatures.
January 1996, Developments in biological standardization,
N S Pangi, and J M Master, and K H Dave
Stabilising oral poliovaccine at high ambient temperatures.
January 1995, Vaccine,
N S Pangi, and J M Master, and K H Dave
Antibody responses to British trivalent oral poliovaccine.
April 1963, Lancet (London, England),
N S Pangi, and J M Master, and K H Dave
Neurovirulence testing of oral poliovaccine in the rhesus monkey.
July 1976, Indian journal of pathology & microbiology,
N S Pangi, and J M Master, and K H Dave
Efficacy and safety of oral sotalol in early infancy.
November 1991, Pacing and clinical electrophysiology : PACE,
Copied contents to your clipboard!